rs121913005
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM1PM2PM5BP4
The NM_001927.4(DES):c.1325C>A(p.Thr442Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000476 in 1,595,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T442I) has been classified as Pathogenic.
Frequency
Consequence
NM_001927.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DES | NM_001927.4 | c.1325C>A | p.Thr442Asn | missense_variant | 8/9 | ENST00000373960.4 | NP_001918.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DES | ENST00000373960.4 | c.1325C>A | p.Thr442Asn | missense_variant | 8/9 | 1 | NM_001927.4 | ENSP00000363071.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151928Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000449 AC: 1AN: 222748Hom.: 0 AF XY: 0.00000838 AC XY: 1AN XY: 119348
GnomAD4 exome AF: 0.0000506 AC: 73AN: 1443900Hom.: 0 Cov.: 31 AF XY: 0.0000531 AC XY: 38AN XY: 716136
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151928Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74184
ClinVar
Submissions by phenotype
Desmin-related myofibrillar myopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2023 | This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 442 of the DES protein (p.Thr442Asn). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DES-related conditions. ClinVar contains an entry for this variant (Variation ID: 626715). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DES protein function. This variant disrupts the p.Thr442 amino acid residue in DES. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17221859, 18653338, 21262226, 22153487, 22215463). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 19, 2023 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jul 04, 2022 | - - |
Desmin-related myofibrillar myopathy;C1858154:Dilated cardiomyopathy 1I;C1867005:Neurogenic scapuloperoneal syndrome, Kaeser type Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 21, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 626715; Landrum et al., 2016); Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26582918, 27535533) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 05, 2019 | The p.T442N variant (also known as c.1325C>A), located in coding exon 8 of the DES gene, results from a C to A substitution at nucleotide position 1325. The threonine at codon 442 is replaced by asparagine, an amino acid with similar properties. A different variant affecting this codon (p.T442I, c.1325C>T) has been reported in association with desminopathy with cardiac and skeletal system involvement (Bär H et al. Hum. Mutat., 2007 Apr;28:374-86). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at